Top

BMC Cardiovascular Disorders

Published in:

Open Access 01-12-2018 | Research article

Dietary intervention with a specific micronutrient combination for the treatment of patients with cardiac arrhythmias: the impact on insulin resistance and left ventricular function

Authors: Elke Parsi, Norman Bitterlich, Anne Winkelmann, Daniela Rösler, Christine Metzner

Published in: BMC Cardiovascular Disorders | Issue 1/2018

Abstract

Background

Cardiac arrhythmias (CA) are very common and may occur with or without heart disease. Causes of these disturbances can be components of the metabolic syndrome (MetS) or deficits of micronutrients especially magnesium, potassium, B vitamins and coenzyme Q10. Both causes may also influence each other. Insulin resistance (IR) is a risk factor for diastolic dysfunction. One exploratory outcome of the present pilot study was to assess the impact of a dietary intervention with specific micronutrients on the lowering of IR levels in patients with CA with the goal to improve the left ventricular (LV) function.

Methods

This was a post hoc analysis of the randomized double blind, placebo-controlled pilot study in patients with CA (VPBs, SVPBs, SV tachycardia), which were recruited using data from patients who were 18–75 years of age in an Outpatient Practice of Cardiology. These arrhythmias were assessed by Holter ECG and LV function by standard echocardiography. Glucose metabolism was measured by fasting glucose, fasting insulin level and the Homeostasis Model Assessment of IR (HOMA-IR) at baseline and after 6 weeks of dietary supplementation.

Results

A total of 54 randomized patients with CA received either a specific micronutrient combination or placebo. Dietary intervention led to a significant decrease in fasting insulin ≥58 pmol/l (p = 0.020), and HOMA-IR (p = 0.053) in the verum group after 6 weeks. At the same time, parameters of LV diastolic function were improved after intervention in the verum group: significant reduction of LV mass index (p = 0.003), and in tendency both a decrease of interventricular septal thickness (p = 0.053) as well as an increase of E/A ratio (p = 0.051). On the other hand, the premature beats (PBs) were unchanged under verum.

Conclusions

In this pilot study, dietary intervention with specific micronutrient combination as add-on to concomitant cardiovascular drug treatment seems to improve cardio metabolic health in patients with CA. Further studies are required.

Study registration

The study was approved by the Freiburg Ethics Commission International and was retrospectively registered with the U.S. National Institutes of Health Clinical Trials gov ID NCT 02652338 on 16 December 2015.

Conen D, Adam M, Roche F, Barthelemy J-C, Felber Dietrich D, Imboden M, et al. Premature atrial contractions in the general population: frequency and risk factors. Circulation. 2012;126:2302–8. https://doi.org/10.1161/CIRCULATIONAHA.112.112300.CrossRefPubMed

Massing MW, Simpson RJ Jr, Rautaharju PM, Schreiner PJ, Crow R, Heiss G. Usefulness of ventricular premature complexes to predict coronary heart disease events and mortality (from the atherosclerosis risk in communities cohort). Am J Cardiol. 2006;98:1609–12. https://doi.org/10.1016/j.amjcard.2006.06.061.CrossRefPubMed

Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of diabetes (EASD). Eur Heart J. 2013;34:3035–87. https://doi.org/10.1093/eurheartj/eht108.CrossRefPubMed

Ayalon N, Gopal DM, Mooney DM, Simonetti JS, Grossman JR, Dwivedi A, et al. Preclinical left ventricular diastolic dysfunction in metabolic syndrome. Am J Cardiol. 2014;114:838–42. https://doi.org/10.1016/j.amjcard.2014.06.013.CrossRefPubMedPubMedCentral

Azevedo A, Bettencourt P, Almeida PB, Santos AC, Abreu-Lima C, Hense H-W, Barros H. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities—cross-sectional study of the general population. BMC Cardiovasc Disord. 2007;7:17. https://doi.org/10.1186/1471-2261-7-17.CrossRefPubMedPubMedCentral

Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol. 2006;48:1548–51. https://doi.org/10.1016/j.jacc.2006.07.033.CrossRefPubMed

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J heart fail. 2016. https://doi.org/10.1002/ejhf.592.

Bashir Y, Sneddon JF, Staunton HA, Haywood GA, Simpson IA, McKenna WJ, Camm AJ. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1993;72:1156–62.CrossRefPubMed

Falco CN, Grupi C, Sosa E, Scanavacca M, Hachul D, Lara S, et al. Successful improvement of frequency and symptoms of premature complexes after oral magnesium administration. Arq Bras Cardiol. 2012;98:480–7.CrossRefPubMed

10.

Geiger H, Wanner C. Magnesium in disease. Clin Kidney J. 2012;5:i25–38. https://doi.org/10.1093/ndtplus/sfr165.CrossRefPubMedPubMedCentral

11.

Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005;28:1438–44.CrossRefPubMed

12.

Stühlinger HG. Die Bedeutung von Magnesium bei kardiovaskulären Erkrankungen. J Kardiol. 2002;9:389–95.

13.

Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346:f1378. https://doi.org/10.1136/bmj.f1378.CrossRefPubMedPubMedCentral

14.

Child DF, Hudson PR, Jones H, Davies GK, De P, Mukherjee S, et al. The effect of oral folic acid on glutathione, glycaemia and lipids in type 2 diabetes. Diabetes Nutr Metab. 2004;17:95–102.PubMed

15.

Ho M, Halim JH, Gow ML, El-Haddad N, Marzulli T, Baur LA, et al. Vitamin B12 in obese adolescents with clinical features of insulin resistance. Nutrients. 2014;6:5611–8. https://doi.org/10.3390/nu6125611.CrossRefPubMedPubMedCentral

16.

Knight BA, Shields BM, Brook A, Hill A, Bhat DS, Hattersley AT, Yajnik CS. Lower circulating B12 is associated with higher obesity and insulin resistance during pregnancy in a non-diabetic white British population. PLoS One. 2015;10:e0135268. https://doi.org/10.1371/journal.pone.0135268.CrossRefPubMedPubMedCentral

17.

Sazonov V, Maccubbin D, Sisk CM, Canner PL. Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose. Int J Clin Pract. 2013;67:297–302. https://doi.org/10.1111/ijcp.12089.CrossRefPubMed

18.

Schwab S, Zierer A, Heier M, Fischer B, Huth C, Baumert J, et al. Intake of vitamin and mineral supplements and longitudinal association with HbA1c levels in the general non-diabetic population—results from the MONICA/KORA S3/F3 study. PLoS One. 2015;10:e0139244. https://doi.org/10.1371/journal.pone.0139244.CrossRefPubMedPubMedCentral

19.

Sudchada P, Saokaew S, Sridetch S, Incampa S, Jaiyen S, Khaithong W. Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2012;98:151–8. https://doi.org/10.1016/j.diabres.2012.05.027.CrossRefPubMed

20.

Moazen M, Mazloom Z, Ahmadi A, Dabbaghmanesh MH, Roosta S. Effect of coenzyme Q10 on glycaemic control, oxidative stress and adiponectin in type 2 diabetes. J Pak Med Assoc. 2015;65:404–8.PubMed

21.

Raygan F, Rezavandi Z, Dadkhah Tehrani S, Farrokhian A, Asemi Z. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome. Eur J Nutr. 2015. https://doi.org/10.1007/s00394-015-1042-7.

22.

Shargorodsky M, Debby O, Matas Z, Zimlichman R. Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors. Nutr Metab (Lond). 2010;7:55. https://doi.org/10.1186/1743-7075-7-55.CrossRef

23.

Turk S, Baki A, Solak Y, Kayrak M, Atalay H, Gaipov A, et al. Coenzyme Q10 supplementation and diastolic heart functions in hemodialysis patients: a randomized double-blind placebo-controlled trial. Hemodial Int. 2013;17:374–81. https://doi.org/10.1111/hdi.12022.CrossRefPubMed

24.

Zahedi H, Eghtesadi S, Seifirad S, Rezaee N, Shidfar F, Heydari I, et al. Effects of CoQ10 supplementation on lipid profiles and glycemic control in patients with type 2 diabetes: a randomized, double blind, placebo-controlled trial. J Diabetes Metab Disord. 2014;13:81. https://doi.org/10.1186/s40200-014-0081-6.CrossRefPubMedPubMedCentral

25.

Classen HG, Grober U, Kisters K. Drug-induced magnesium deficiency. Med Monatsschr Pharm. 2012;35:274–80.PubMed

26.

Kaye P. The role of magnesium in the emergency department. Emerg Med J. 2002;19:288–91. https://doi.org/10.1136/emj.19.4.288.CrossRefPubMedPubMedCentral

27.

Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–62. https://doi.org/10.1016/S0140-6736(05)67402-8.CrossRefPubMed

28.

Schneider HJ, Friedrich N, Klotsche J, Pieper L, Nauck M, John U, et al. The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab. 2010;95:1777–85. https://doi.org/10.1210/jc.2009-1584.CrossRefPubMed

29.

Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev. 2010;23:247–69. https://doi.org/10.1017/S0954422410000144.CrossRefPubMed

30.

Prineas RJ, Crow RS, Blackburn HW. The Minnesota code manual of electrocardiographic findings: Standards and procedures for measurement and classification. Boston, Mass.: J. Wright; 1982.

31.

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–70. https://doi.org/10.1093/ehjci/jev014.CrossRef

32.

Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009;22:107–33. https://doi.org/10.1016/j.echo.2008.11.023.CrossRef

33.

Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: L. Erlbaum Associates; 1988.

34.

Moebus S, Hanisch J, Bramlage P, Losch C, Hauner H, Wasem J, Jockel K-H. Regional differences in the prevalence of the metabolic syndrome in primary care practices in Germany. Dtsch Arztebl Int. 2008;105:207–13. https://doi.org/10.3238/artzebl.2008.0207.CrossRefPubMedPubMedCentral

35.

von Bibra H, Paulus WJ, St John Sutton M, Leclerque C, Schuster T, Schumm-Draeger P-M. Quantification of diastolic dysfunction via the age dependence of diastolic function - impact of insulin resistance with and without type 2 diabetes. Int J Cardiol. 2015;182:368–74. https://doi.org/10.1016/j.ijcard.2014.12.005.CrossRef

36.

Koliaki C, Roden M. Alterations of mitochondrial function and insulin sensitivity in human obesity and diabetes mellitus. Annu Rev Nutr. 2016;36:337–67. https://doi.org/10.1146/annurev-nutr-071715-050656.CrossRefPubMed

37.

von Bibra H, Paulus W. Diastolische Dysfunktion. Kardiologe. 2016;10:47–55. https://doi.org/10.1007/s12181-015-0035-3.CrossRef

38.

Fontes-Carvalho R, Ladeiras-Lopes R, Bettencourt P, Leite-Moreira A, Azevedo A. Diastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes. Cardiovasc Diabetol. 2015;14:4. https://doi.org/10.1186/s12933-014-0168-x.CrossRefPubMedPubMedCentral

39.

Littarru GP, Tiano L. Clinical aspects of coenzyme Q10: an update. Nutrition. 2010;26:250–4. https://doi.org/10.1016/j.nut.2009.08.008.CrossRefPubMed

40.

Quiles JL, Ochoa JJ, Battino M, Gutierrez-Rios P, Nepomuceno EA, Frias ML, et al. Life-long supplementation with a low dosage of coenzyme Q10 in the rat: effects on antioxidant status and DNA damage. Biofactors. 2005;25:73–86.CrossRefPubMed

41.

Ikee R, Hamasaki Y, Oka M, Maesato K, Mano T, Moriya H, et al. High-density lipoprotein cholesterol and left ventricular mass index in peritoneal dialysis. Perit Dial Int. 2008;28:611–6.PubMed

42.

Ahn M-S, Kim J-Y, Youn YJ, Kim S-Y, Koh S-B, Lee K, et al. Cardiovascular parameters correlated with metabolic syndrome in a rural community cohort of Korea: the ARIRANG study. J Korean Med Sci. 2010;25:1045–52. https://doi.org/10.3346/jkms.2010.25.7.1045.CrossRefPubMedPubMedCentral

43.

Ochi A, Ishimura E, Tsujimoto Y, Kakiya R, Tabata T, Mori K, et al. Hair magnesium, but not serum magnesium, is associated with left ventricular wall thickness in hemodialysis patients. Circ J. 2013;77:3029–36.CrossRefPubMed

44.

Grober U, Schmidt J, Kisters K. Magnesium in prevention and therapy. Nutrients. 2015;7:8199–226. https://doi.org/10.3390/nu7095388.CrossRefPubMedPubMedCentral

45.

DiNicolantonio JJ, Bhutani J, McCarty MF, O’Keefe JH. Coenzyme Q10 for the treatment of heart failure: a review of the literature. Open Heart. 2015;2:e000326. https://doi.org/10.1136/openhrt-2015-000326.CrossRefPubMedPubMedCentral

46.

Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham heart study. Circulation. 2003;107:448–54.CrossRefPubMed

47.

Hwang Y-C, Jee JH, Kang M, Rhee E-J, Sung J, Lee M-K. Metabolic syndrome and insulin resistance are associated with abnormal left ventricular diastolic function and structure independent of blood pressure and fasting plasma glucose level. Int J Cardiol. 2012;159:107–11. https://doi.org/10.1016/j.ijcard.2011.02.039.CrossRefPubMed

48.

Velagaleti RS, Gona P, Chuang ML, Salton CJ, Fox CS, Blease SJ, et al. Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham heart study. Circ Cardiovasc Imaging. 2010;3:257–63. https://doi.org/10.1161/CIRCIMAGING.109.911438.CrossRefPubMedPubMedCentral

49.

Majahalme S, Turjanmaa V, Weder A, Lu H, Tuomisto M, Virjo A, Uusitalo A. Blood pressure levels and variability, smoking, and left ventricular structure in normotension and in borderline and mild hypertension. Am J Hypertens. 1996;9:1110–8.CrossRefPubMed

50.

Sundström J, Lind L, Nyström N, Zethelius B, Andrén B, Hales CN, Lithell HO. Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men. Circulation. 2000;101:2595–600.CrossRefPubMed

51.

Zhang L, Jaswal JS, Ussher JR, Sankaralingam S, Wagg C, Zaugg M, Lopaschuk GD. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Circ Heart Fail. 2013;6:1039–48. https://doi.org/10.1161/CIRCHEARTFAILURE.112.000228.CrossRefPubMed

52.

Verma S, Garg A, Yan AT, Gupta AK, Al-Omran M, Sabongui A, et al. Effect of Empagliflozin on left ventricular mass and diastolic function in individuals with diabetes: an important clue to the EMPA-REG OUTCOME trial? Diabetes Care. 2016;39:e212–3. https://doi.org/10.2337/dc16-1312.CrossRefPubMed

53.

Chutia H, Lynrah KG. Association of Serum Magnesium Deficiency with insulin resistance in type 2 diabetes mellitus. J Lab Physicians. 2015;7:75–8. https://doi.org/10.4103/0974-2727.163131.CrossRefPubMedPubMedCentral

54.

DGE. Referenzwerte für die Nährstoffzufuhr. 2nd ed. Neustadt an der Weinstrasse: Neuer Umschau Buchverlag; 2015.

55.

Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103:1813–8.CrossRefPubMed

Title: Dietary intervention with a specific micronutrient combination for the treatment of patients with cardiac arrhythmias: the impact on insulin resistance and left ventricular function
Authors: Elke Parsi
Norman Bitterlich
Anne Winkelmann
Daniela Rösler
Christine Metzner
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: BMC Cardiovascular Disorders / Issue 1/2018
Electronic ISSN: 1471-2261
DOI: https://doi.org/10.1186/s12872-018-0954-6

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Dietary intervention with a specific micronutrient combination for the treatment of patients with cardiac arrhythmias: the impact on insulin resistance and left ventricular function

Abstract

Background

Methods

Results

Conclusions

Study registration

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Study registration

Please log in to get access to this content

Other articles of this Issue 1/2018

Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation

Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon

Use of speckle-tracking echocardiography–derived strain and systolic strain rate measurements to predict rejection in transplant hearts with preserved ejection fraction

Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting

Association between skeletal muscle mass to visceral fat area ratio and arterial stiffness in Chinese patients with type 2 diabetes mellitus

New anthropometric indices or old ones: which perform better in estimating cardiovascular risks in Chinese adults

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page